These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 142300

  • 1. Emergence of foreign H-2-like cytotoxicity and transplantation targets on vaccinia and Moloney virus-infected Meth. A tumour cells.
    Matossian-Rogers A, Garrido F, Festenstein H.
    Scand J Immunol; 1977; 6(5):541-6. PubMed ID: 142300
    [Abstract] [Full Text] [Related]

  • 2. Relationships between H-2 and viral antigens in murine oncornavirus-induced tumours.
    Gomard E, Duprez V, Henin Y, Levy JP.
    J Immunogenet; 1977 Feb; 4(1):35-45. PubMed ID: 192802
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity against tumour-associated antigens not H-2 restricted.
    Holden HT, Herberman RB.
    Nature; 1977 Jul 21; 268(5617):250-2. PubMed ID: 69992
    [No Abstract] [Full Text] [Related]

  • 4. Private specificities of H-2K and H-2D loci as possible selective targets for effector lymphocytes in cell-mediated immunity.
    Brondz BD, Egorov IK, Drizlikh GI.
    J Exp Med; 1975 Jan 01; 141(1):11-26. PubMed ID: 46906
    [Abstract] [Full Text] [Related]

  • 5. Anti-viral immune response of allogeneic irradiation bone marrow chimeras: cytotoxic T cell responsiveness depends upon H-2 combination and infectious agent.
    Zinkernagel RM, Sado T, Althage A, Kamisaku H.
    Eur J Immunol; 1984 Jan 01; 14(1):14-23. PubMed ID: 6198181
    [Abstract] [Full Text] [Related]

  • 6. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ, Boes J, Melief CJ.
    J Immunol; 1984 Jul 01; 133(1):28-32. PubMed ID: 6202783
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated cytotoxicity to moloney sarcoma in syngeneic and allogeneic rats.
    Veit BC, Feldman JD.
    Int J Cancer; 1975 Mar 15; 15(3):367-76. PubMed ID: 1079791
    [Abstract] [Full Text] [Related]

  • 8. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK, Ames RS, McIntire RK, Herberman RB.
    Cancer Res; 1979 Dec 15; 39(12):4887-93. PubMed ID: 387218
    [Abstract] [Full Text] [Related]

  • 9. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F, Jongeneel CV.
    J Immunol; 1977 Aug 15; 119(2):623-9. PubMed ID: 196025
    [No Abstract] [Full Text] [Related]

  • 10. Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.
    Herberman RB, Nunn ME, Lavrin DH, Asofsky R.
    J Natl Cancer Inst; 1973 Nov 15; 51(5):1509-12. PubMed ID: 4543478
    [No Abstract] [Full Text] [Related]

  • 11. Cytotoxic interactions of virus specific effector cells with virus infected targets of different cell type.
    Koszinowski U, Ertl H.
    J Immunogenet; 1977 Apr 15; 4(2):107-14. PubMed ID: 194984
    [Abstract] [Full Text] [Related]

  • 12. H-2 restriction of virus-specific cytotoxicity across the H-2 barrier. Separate effector T-cell specificities are associated with self-H-2 and with the tolerated allogeneic H-2 in chimeras.
    Zinkernagel RM.
    J Exp Med; 1976 Oct 01; 144(4):933-45. PubMed ID: 62016
    [Abstract] [Full Text] [Related]

  • 13. Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells.
    Koszinowski U, Thomssen R.
    Eur J Immunol; 1975 Apr 01; 5(4):245-51. PubMed ID: 1086229
    [Abstract] [Full Text] [Related]

  • 14. Immunogenetic studies on meth-A-vaccinia tumour cells in vivo and in vitro.
    Garrido F, Schmidt W, Festenstein H.
    J Immunogenet; 1977 Apr 01; 4(2):115-25. PubMed ID: 326975
    [No Abstract] [Full Text] [Related]

  • 15. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M, Pearson G, Pettigrew H, Redmon L, Orr T.
    Cancer Res; 1973 Nov 01; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract] [Full Text] [Related]

  • 16. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D, Parenti A, Biasi G, Chieco-Bianchi L, Colombatti A.
    J Natl Cancer Inst; 1978 Sep 01; 61(3):885-90. PubMed ID: 80457
    [Abstract] [Full Text] [Related]

  • 17. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ, Boes J, Melief CJ.
    J Immunol; 1984 Jul 01; 133(1):24-7. PubMed ID: 6202782
    [Abstract] [Full Text] [Related]

  • 18. A large number of T lymphocytes recognize Moloney-murine leukemia virus-induced antigens, but a few mediate long-lasting tumor immunosurveillance.
    Facchinetti A, Dalla Santa S, Mezzalira S, Rosato A, Biasi G.
    J Immunol; 2005 May 01; 174(9):5398-406. PubMed ID: 15843538
    [Abstract] [Full Text] [Related]

  • 19. Multiple H-2 linked immune response gene control of H-2 D-associated T-cell-mediated lympholysis to trinitrophenyl-modified autologous cells: Ir-like genes mapping to the left of I-A and within the I region.
    Schmitt-Verhulst AM, Shearer GM.
    J Exp Med; 1976 Dec 01; 144(6):1701-6. PubMed ID: 1087329
    [Abstract] [Full Text] [Related]

  • 20. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D, Ronchese F, Zanovello P, Biasi G, Chieco-Bianchi L.
    J Immunol; 1982 Feb 01; 128(2):774-9. PubMed ID: 6459385
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.